You are here:

Archived: caffeine citrate (Peyona)


in the absence of a submission from the holder of the marketing authorisation:

caffeine citrate (Peyona®) is not recommended for use within NHS Scotland.

Indication under review: treatment of primary apnoea of premature newborns.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: caffeine citrate (Peyona)
SMC Drug ID: 814/12
Manufacturer: Chiesi Pharmaceuticals/Trinity Pharmaceuticals
Indication: for the treatment of primary apnoea of premature newborns.
BNF Category:
Sub Category: 3.5 Respiratory stimulants and pulmonary surfactants
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 8 October 2012

Current Advice

Full submission 9 September 2013